32.20 USD
↘ 0.76 (2.31%)AT CLOSE (11:59 AM EDT)
Harmony Biosciences Holdings, Inc. Common Stock
HRMYNASDAQ • USD
31.97
↘ 0.24 (0.73%)
POST MARKET (AS OF 07:40 PM EDT)
Post Market
AS OF 07:40 PM EDT
31.97
↘ 0.24 (0.73%)
Market: CLOSED
Open?$33.00
High?$33.20
Low?$32.06
Prev. Close?$32.96
Volume?462.3K
Avg. Volume?757.1K
VWAP?$32.50
Rel. Volume?0.61x
Bid / Ask
Bid?$31.50 × 400
Ask?$32.20 × 300
Spread?$0.70
Midpoint?$31.85
Valuation & Ratios
Market Cap?1.9B
Shares Out?57.9M
Float?47.3M
Float %?82.1%
P/E Ratio?12.80
P/B Ratio?2.05
EPS?$2.52
Dividend?0.00%
Ex-Dividend?N/A
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades at $32.20 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest HRMY is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Themes
Employees
293
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-08-19
Address
630 W GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?98
Momentum?60
Short Sent.?54
Piotroski F-Score?3/9Weak
Altman Z-Score?5.04Safe
Confidence?53%Low
Short InterestHigh
Short % of Float?14.00%High
Short Interest?6.6M
Days to Cover?8.2
Free Float47.3M
Avg Daily Volume805.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.58Strong
Quick Ratio?3.56Strong
Cash Ratio?2.71Strong
Debt/Equity?0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?12.8CHEAP▾
Peers100
S&P88
P/B?2.05CHEAP▾
Peers100
S&P73
P/S?2.07CHEAP▾
Peers100
S&P65
P/FCF?5.5CHEAP▾
Peers100
S&P97
EV/EBITDA?6.7CHEAP▾
Peers100
S&P95
EV/Sales?1.59CHEAP▾
Peers100
S&P82
Returns & Efficiency
ROE?16.0%STRONG▾
Peers50
S&P57
ROA?11.5%STRONG▾
Peers50
S&P79
Cash Flow & Enterprise
FCF?$341.8M
Enterprise Value?$1.4B
Fundamentals ratios updated end of day